{"symbol":"GILD","fiscalQuarter":"Q2-2023","reportDate":"2023-08-03","reportTime":"AMC","status":"reported","company":{"name":"Gilead Sciences, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/GILD/earnings/Q2-2023","postBrief":{"headline":"Gilead Sciences Misses on EPS, Stock Down N/A%","keyNumbers":[{"metric":"EPS","actual":"$1.34","expected":"N/A","surprise":"-16.09%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management acknowledged challenges in the current market environment.","They emphasized a focus on long-term growth despite short-term setbacks."],"summary":"Management expressed concerns about market conditions impacting performance. They remain focused on strategic initiatives to drive future growth."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Gilead Sciences reported a lower-than-expected EPS, indicating potential challenges in their financial performance. The lack of revenue data and guidance leaves investors uncertain about future prospects. The stock reaction is not available, but the earnings miss may lead to cautious sentiment among investors.","metaDescription":"Gilead Sciences (GILD) Q2 2023 earnings: EPS missed expectations. Stock reaction not available. Full breakdown."}}